<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30449229</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>19</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1473-0766</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Nov</Month>                        <Day>19</Day>                    </PubDate>                </JournalIssue>                <Title>Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology</Title>                <ISOAbbreviation>Gynecol. Endocrinol.</ISOAbbreviation>            </Journal>            <ArticleTitle>Breast metastasis two years after pelvic surgery and adjuvant chemotherapy for serous ovarian cancer.</ArticleTitle>            <Pagination>                <MedlinePgn>1-3</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1080/09513590.2018.1521795</ELocationID>            <Abstract>                <AbstractText>Ovarian cancer is considered the leading cause of death among gynecologic neoplasias. Breast metastases from primary ovarian cancer have been reported in only 0.03-0.6% of all breast cancers. A 38-year-old female, multipara, affected by advanced ovarian cancer and undergone a total abdominal hysterectomy with bilateral salpingo-oophorectomy, omentectomy, and pelvic peritonectomy two years earlier, was discovered to have a breast metastasis. She underwent a quadrantectomy (QSI) with an open biopsy of nodularity attached to the pectoral muscle fascia: on definitive histological characterization the breast lesions showed a high-grade invasive carcinoma, with papillary serum differentiation, and the immunohistochemistry study of breast lesion showed positivity for cytokeratin 7 and an extensive positivity for Wilm's tumor (WT)-1 and paired box 8 (PAX8). These aspects are indicative of mammary metastasis from carcinoma of ovarian origin. Despite their rarity, metastases to breast from ovarian cancer should be considered possible because their recognition and differentiation compared to primary tumors are crucial for prognosis. Future clinical studies on MOCB should be performed to discover new specific markers for a more accurate histopathological diagnosis and to establish the real need of surgical treatment.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Della Corte</LastName>                    <ForeName>Luigi</ForeName>                    <Initials>L</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-0584-2181</Identifier>                    <AffiliationInfo>                        <Affiliation>a Department of Neuroscience, Reproductive Sciences and Dentistry , University of Naples Federico II , Naples , Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Giampaolino</LastName>                    <ForeName>Pierluigi</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>b Department of Public Health , University of Naples Federico II , Naples , Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Fabozzi</LastName>                    <ForeName>Annamaria</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>b Department of Public Health , University of Naples Federico II , Naples , Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Cieri</LastName>                    <ForeName>Miriam</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>c Department of Advanced Biomedical Sciences , University of Naples Federico II , Naples , Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zizolfi</LastName>                    <ForeName>Brunella</ForeName>                    <Initials>B</Initials>                    <AffiliationInfo>                        <Affiliation>a Department of Neuroscience, Reproductive Sciences and Dentistry , University of Naples Federico II , Naples , Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Morra</LastName>                    <ForeName>Ilaria</ForeName>                    <Initials>I</Initials>                    <AffiliationInfo>                        <Affiliation>a Department of Neuroscience, Reproductive Sciences and Dentistry , University of Naples Federico II , Naples , Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bifulco</LastName>                    <ForeName>Giuseppe</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>a Department of Neuroscience, Reproductive Sciences and Dentistry , University of Naples Federico II , Naples , Italy.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>11</Month>                <Day>19</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Gynecol Endocrinol</MedlineTA>            <NlmUniqueID>8807913</NlmUniqueID>            <ISSNLinking>0951-3590</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Ovarian cancer</Keyword>            <Keyword MajorTopicYN="N">breast metastasis</Keyword>            <Keyword MajorTopicYN="N">chemotherapy</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>11</Month>                <Day>20</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>11</Month>                <Day>20</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>11</Month>                <Day>20</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30449229</ArticleId>            <ArticleId IdType="doi">10.1080/09513590.2018.1521795</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>